{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:52Z","timestamp":1792782712492,"version":"4.5.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"ESSCO-MGH Breast Cancer Research Fund","id":[{"id":"https:\/\/ror.org\/03xzf6x18","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00520-026-10343-4","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:46:18Z","timestamp":1768995978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Use of supportive care services and advance care planning among early phase oncology clinical trial participants"],"prefix":"10.1007","volume":"34","author":[{"given":"Leah L.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Bame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Florissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope","family":"Heldreth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Boulanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casandra","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Juric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Nipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra M.","family":"Lundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel B.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"9","key":"10343_CR1","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1200\/JCO.2010.34.5074","volume":"30","author":"D Olmos","year":"2012","unstructured":"Olmos D, A\u2019hern RP, Marsoni S et al (2012) Patient selection for oncology phase I trials: a multi-institutional study of prognostic factors. J Clin Oncol. 30(9):996\u20131004. https:\/\/doi.org\/10.1200\/JCO.2010.34.5074","journal-title":"J Clin Oncol."},{"issue":"22","key":"10343_CR2","doi-asserted-by":"publisher","first-page":"19316","DOI":"10.18632\/oncotarget.2909","volume":"6","author":"DM Hyman","year":"2015","unstructured":"Hyman DM, Eaton AA, Gounder MM et al (2015) Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials. Oncotarget 6(22):19316\u201319327. https:\/\/doi.org\/10.18632\/oncotarget.2909","journal-title":"Oncotarget"},{"issue":"10","key":"10343_CR3","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.3390\/CANCERS13102304","volume":"13","author":"JAJ Douma","year":"2021","unstructured":"Douma JAJ, Buffart LM, Sedhom R et al (2021) Clinical predictors of early trial discontinuation for patients participating in phase I clinical trials in oncology. Cancers (Basel) 13(10):2304. https:\/\/doi.org\/10.3390\/CANCERS13102304","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10343_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1200\/PO.20.00214","volume":"5","author":"MP Mackley","year":"2021","unstructured":"Mackley MP, Fernandez NR, Fletcher B, Woolcott CG, Fernandez CV (2021) Revisiting Risk and Benefit in Early Oncology Trials in the Era of Precision Medicine: A Systematic Review and Meta-Analysis of Phase I Trials of Targeted Single-Agent Anticancer Therapies. JCO Precis Oncol 5(5):17\u201326. https:\/\/doi.org\/10.1200\/PO.20.00214","journal-title":"JCO Precis Oncol"},{"key":"10343_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/J.CRITREVONC.2024.104307","author":"P Corbaux","year":"2024","unstructured":"Corbaux P, Bayle A, Besle S et al (2024) Patients\u2019 selection and trial matching in early-phase oncology clinical trials. Crit Rev Oncol Hematol. https:\/\/doi.org\/10.1016\/J.CRITREVONC.2024.104307","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10343_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/J.CRITREVONC.2011.11.008","volume":"83","author":"A Ploquin","year":"2012","unstructured":"Ploquin A, Olmos D, Fert\u00e9 C et al (2012) Life-expectancy of patients enrolled in phase 1 clinical trials: a systematic review of published prognostic models. Crit Rev Oncol Hematol 83(2):242\u2013248. https:\/\/doi.org\/10.1016\/J.CRITREVONC.2011.11.008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10343_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/JNCICS\/PKZ071","author":"D Day","year":"2019","unstructured":"Day D, Guo C, Kanjanapan Y et al (2019) Survival in early phase immuno-oncology trials: development and validation of a prognostic index. JNCI Cancer Spectr. https:\/\/doi.org\/10.1093\/JNCICS\/PKZ071","journal-title":"JNCI Cancer Spectr"},{"issue":"23","key":"10343_CR8","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1056\/NEJMC1803837","volume":"378","author":"C Chakiba","year":"2018","unstructured":"Chakiba C, Grellety T, Bellera C, Italiano A (2018) Encouraging trends in modern phase 1 oncology trials. N Engl J Med 378(23):2242\u20132243. https:\/\/doi.org\/10.1056\/NEJMC1803837","journal-title":"N Engl J Med"},{"issue":"2","key":"10343_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/NRCLINONC.2015.194","volume":"13","author":"KM Wong","year":"2016","unstructured":"Wong KM, Capasso A, Eckhardt SG (2016) The changing landscape of phase I trials in oncology. Nat Rev Clin Oncol 13(2):106\u2013117. https:\/\/doi.org\/10.1038\/NRCLINONC.2015.194","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10343_CR10","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1200\/JOP.2016.020743","volume":"13","author":"MK Kirkwood","year":"2017","unstructured":"Kirkwood MK (2017) The State of Cancer Care in America, 2017: A Report by the American Society of Clinical Oncology. J Oncol Pract 13(4):e353\u2013e394. https:\/\/doi.org\/10.1200\/JOP.2016.020743","journal-title":"J Oncol Pract"},{"issue":"12","key":"10343_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/S41571-019-0262-9","volume":"16","author":"JJ Adashek","year":"2019","unstructured":"Adashek JJ, LoRusso PM, Hong DS, Kurzrock R (2019) Phase i trials as valid therapeutic options for patients with cancer. Nat Rev Clin Oncol 16(12):773\u2013778. https:\/\/doi.org\/10.1038\/S41571-019-0262-9","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10343_CR12","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/ANNONC\/MDM548","volume":"19","author":"A Italiano","year":"2008","unstructured":"Italiano A, Massard C, Bahleda R et al (2008) Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy. Ann Oncol 19(4):787\u2013792. https:\/\/doi.org\/10.1093\/ANNONC\/MDM548","journal-title":"Ann Oncol"},{"issue":"11","key":"10343_CR13","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/J.EJCA.2008.04.017","volume":"44","author":"HT Arkenau","year":"2008","unstructured":"Arkenau HT, Olmos D, Ang JE et al (2008) 90-Days mortality rate in patients treated within the context of a phase-I trial: how should we identify patients who should not go on trial? Eur J Cancer 44(11):1536\u20131540. https:\/\/doi.org\/10.1016\/J.EJCA.2008.04.017","journal-title":"Eur J Cancer"},{"issue":"18","key":"10343_CR14","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1002\/CNCR.25389","volume":"116","author":"D Hui","year":"2010","unstructured":"Hui D, Parsons H, Nguyen L et al (2010) Timing of Palliative Care Referral and Symptom Burden in Phase I Cancer Patients: A Retrospective Cohort Study. Cancer 116(18):4402. https:\/\/doi.org\/10.1002\/CNCR.25389","journal-title":"Cancer"},{"issue":"30","key":"10343_CR15","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1200\/JCO.21.02125","volume":"40","author":"M Bittlinger","year":"2022","unstructured":"Bittlinger M, Bicer S, Peppercorn J, Kimmelman J (2022) Ethical considerations for phase i trials in oncology. J Clin Oncol 40(30):3474\u20133488. https:\/\/doi.org\/10.1200\/JCO.21.02125","journal-title":"J Clin Oncol"},{"issue":"2","key":"10343_CR16","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/CNCR.24025","volume":"115","author":"E Finlay","year":"2009","unstructured":"Finlay E, Lu HL, Henderson H, O\u2019Dwyer PJ, Casarett DJ (2009) Do phase 1 patients have greater needs for palliative care compared with other cancer patients? Cancer 115(2):446\u2013453. https:\/\/doi.org\/10.1002\/CNCR.24025","journal-title":"Cancer"},{"issue":"2","key":"10343_CR17","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1200\/OP.20.00646\/ASSET\/IMAGES\/LARGE\/OP.20.00646T4.JPEG","volume":"17","author":"FJ Hlubocky","year":"2021","unstructured":"Hlubocky FJ, Sher TG, Cella D, Wroblewski KE, Peppercorn J, Daugherty CK (2021) Anxiety Shapes Expectations of Therapeutic Benefit in Phase I Trials for Patients With Advanced Cancer and Spousal Caregivers. JCO Oncol Pract 17(2):e101\u2013e110. https:\/\/doi.org\/10.1200\/OP.20.00646\/ASSET\/IMAGES\/LARGE\/OP.20.00646T4.JPEG","journal-title":"JCO Oncol Pract"},{"issue":"13","key":"10343_CR18","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1002\/CAM4.3971","volume":"10","author":"M Treasure","year":"2021","unstructured":"Treasure M, Daly B, Cao S et al (2021) A randomized controlled trial of structured palliative care versus standard supportive care for patients enrolled in phase 1 clinical trials. Cancer Med 10(13):4312\u20134321. https:\/\/doi.org\/10.1002\/CAM4.3971","journal-title":"Cancer Med"},{"issue":"3","key":"10343_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/S11764-021-01014-W","volume":"15","author":"A Hunt","year":"2021","unstructured":"Hunt A, Handorf E, Blau M et al (2021) Psychological distress in patients with metastatic cancer enrolling on phase I clinical trials. J Cancer Surviv 15(3):398\u2013402. https:\/\/doi.org\/10.1007\/S11764-021-01014-W","journal-title":"J Cancer Surviv"},{"issue":"3","key":"10343_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/J.JPAINSYMMAN.2016.02.014","volume":"52","author":"JB Cassel","year":"2016","unstructured":"Cassel JB, Del Fabbro E, Arkenau T et al (2016) Phase i cancer trials and palliative care: antagonism, irrelevance, or synergy? J Pain Symptom Manage 52(3):437\u2013445. https:\/\/doi.org\/10.1016\/J.JPAINSYMMAN.2016.02.014","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10343_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/S00520-017-3879-1","volume":"26","author":"M Treasure","year":"2018","unstructured":"Treasure M, Daly B, Fu P, Kerpedjieva S, Dowlati A, Meropol NJ (2018) Relationship between phase I study duration and symptom burden. Support Care Cancer 26(3):731\u2013737. https:\/\/doi.org\/10.1007\/S00520-017-3879-1","journal-title":"Support Care Cancer"},{"issue":"6","key":"10343_CR22","doi-asserted-by":"publisher","first-page":"e829","DOI":"10.1200\/OP.22.00742\/ASSET\/IMAGES\/LARGE\/OP.22.00742APP1.JPEG","volume":"19","author":"DM Lundquist","year":"2023","unstructured":"Lundquist DM, Jimenez R, Durbin S et al (2023) Identifying Early-Phase Clinical Trial Participants at Risk for Experiencing Worse Clinical Outcomes. JCO Oncol Pract 19(6):e829\u2013e837. https:\/\/doi.org\/10.1200\/OP.22.00742\/ASSET\/IMAGES\/LARGE\/OP.22.00742APP1.JPEG","journal-title":"JCO Oncol Pract"},{"issue":"7","key":"10343_CR23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/1049909111400723","volume":"28","author":"JM Healy","year":"2011","unstructured":"Healy JM, Patel T, Lee S, Sanchez-Reilly S (2011) Do symptoms matter when considering patients for phase I clinical trials?: a pilot study of older adults with advanced cancer. Am J Hosp Palliat Care 28(7):463\u2013466. https:\/\/doi.org\/10.1177\/1049909111400723","journal-title":"Am J Hosp Palliat Care"},{"issue":"6","key":"10343_CR24","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/J.JPAINSYMMAN.2013.07.004","volume":"47","author":"AC Enzinger","year":"2014","unstructured":"Enzinger AC, Zhang B, Weeks JC, Prigerson HG (2014) Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death. J Pain Symptom Manage 47(6):1078\u20131090. https:\/\/doi.org\/10.1016\/J.JPAINSYMMAN.2013.07.004","journal-title":"J Pain Symptom Manage"},{"key":"10343_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/JNCICS\/PKAA067","author":"R Sedhom","year":"2020","unstructured":"Sedhom R, Ferrell B, Ruel N, Koczywas M, Chung V, Smith TJ (2020) Using patient-reported outcomes to describe the patient experience on phase I clinical trials. JNCI Cancer Spectr. https:\/\/doi.org\/10.1093\/JNCICS\/PKAA067","journal-title":"JNCI Cancer Spectr"},{"issue":"4","key":"10343_CR26","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41416-023-02307-w","volume":"129","author":"HJ van Janse Rensburg","year":"2023","unstructured":"van Janse Rensburg HJ, Liu Z, Watson GA et al (2023) A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events. Br J Cancer 129(4):612\u2013619. https:\/\/doi.org\/10.1038\/s41416-023-02307-w","journal-title":"Br J Cancer"},{"key":"10343_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0029330","author":"HA Parsons","year":"2012","unstructured":"Parsons HA, Baracos VE, Dhillon N, Hong DS, Kurzrock R (2012) Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service. PLoS ONE. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0029330","journal-title":"PLoS ONE"},{"issue":"12","key":"10343_CR28","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1089\/JPM.2014.0108","volume":"17","author":"V Sun","year":"2014","unstructured":"Sun V, Cooke L, Chung V, Uman G, Smith TJ, Ferrell B (2014) Feasibility of a palliative care intervention for cancer patients in phase I clinical trials. J Palliat Med 17(12):1365\u20131368. https:\/\/doi.org\/10.1089\/JPM.2014.0108","journal-title":"J Palliat Med"},{"issue":"4","key":"10343_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1089\/jpm.2010.0416","volume":"14","author":"FJ Meyers","year":"2011","unstructured":"Meyers FJ, Carducci M, Loscalzo MJ, Linder J, Greasby T, Beckett LA (2011) Effects of a problem-solving intervention (COPE) on quality of life for patients with advanced cancer on clinical trials and their caregivers: simultaneous care educational intervention (SCEI): linking palliation and clinical trials. J Palliat Med 14(4):465\u2013473. https:\/\/doi.org\/10.1089\/jpm.2010.0416","journal-title":"J Palliat Med"},{"issue":"9","key":"10343_CR30","doi-asserted-by":"publisher","first-page":"e1427","DOI":"10.1200\/OP.21.00697","volume":"18","author":"S Perni","year":"2022","unstructured":"Perni S, Azoba C, Gorton E et al (2022) Financial toxicity, symptom burden, illness perceptions, and communication confidence in cancer clinical trial participants. JCO Oncol Pract 18(9):e1427\u2013e1437. https:\/\/doi.org\/10.1200\/OP.21.00697","journal-title":"JCO Oncol Pract"},{"issue":"8","key":"10343_CR31","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1634\/theoncologist.2019-0146","volume":"24","author":"RD Nipp","year":"2019","unstructured":"Nipp RD, Lee H, Gorton E et al (2019) Addressing the financial burden of cancer clinical trial participation: longitudinal effects of an equity intervention. Oncologist 24(8):1048\u20131055. https:\/\/doi.org\/10.1634\/theoncologist.2019-0146","journal-title":"Oncologist"},{"issue":"7","key":"10343_CR32","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ONCO.13767","volume":"26","author":"RW Huey","year":"2021","unstructured":"Huey RW, George GC, Phillips P et al (2021) Patient-reported out-of-pocket costs and financial toxicity during early-phase oncology clinical trials. Oncologist 26(7):588\u2013596. https:\/\/doi.org\/10.1002\/ONCO.13767","journal-title":"Oncologist"},{"key":"10343_CR33","doi-asserted-by":"publisher","unstructured":"Durbin S, Lundquist D, Pelletier A et al (2023) Financial toxicity, quality of life, symptom burden, and access to resources in early-phase clinical trial (EP-CT) participants 41(16_suppl):6623\u20136623. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_SUPPL.6623","DOI":"10.1200\/JCO.2023.41.16_SUPPL.6623"},{"key":"10343_CR34","doi-asserted-by":"publisher","unstructured":"Durbin S, Lundquist D, Pelletier A et al (2024) Change in financial toxicity during early-phase cancer clinical trial (EP-CT) participation 42 (16_suppl):11119\u201311119. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_SUPPL.11119","DOI":"10.1200\/JCO.2024.42.16_SUPPL.11119"},{"issue":"12","key":"10343_CR35","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1089\/JPM.2017.0158","volume":"20","author":"BR Ferrell","year":"2017","unstructured":"Ferrell BR, Paterson CL, Hughes MT, Chung V, Koczywas M, Smith TJ (2017) Characteristics of participants enrolled onto a randomized controlled trial of palliative care for patients on phase I studies. J Palliat Med 20(12):1338\u20131344. https:\/\/doi.org\/10.1089\/JPM.2017.0158","journal-title":"J Palliat Med"},{"issue":"4","key":"10343_CR36","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1188\/17.CJON.473-479","volume":"21","author":"BR Ferrell","year":"2017","unstructured":"Ferrell BR, Chung V, Koczywas M et al (2017) Palliative Care and Phase 1 Trials: Intervention to improve quality of life and provide education. Clin J Oncol Nurs 21(4):473. https:\/\/doi.org\/10.1188\/17.CJON.473-479","journal-title":"Clin J Oncol Nurs"},{"issue":"6","key":"10343_CR37","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1089\/JPM.2020.0597","volume":"24","author":"B Ferrell","year":"2021","unstructured":"Ferrell B, Chung V, Hughes MT et al (2021) A palliative care intervention for patients on phase 1 studies. J Palliat Med 24(6):846\u2013856. https:\/\/doi.org\/10.1089\/JPM.2020.0597","journal-title":"J Palliat Med"},{"issue":"10","key":"10343_CR38","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1634\/THEONCOLOGIST.2017-0628","volume":"23","author":"HT Borno","year":"2018","unstructured":"Borno HT, Zhang L, Siegel A, Chang E, Ryan CJ (2018) At what cost to clinical trial enrollment? A retrospective study of patient travel burden in cancer clinical trials. Oncologist 23(10):1242. https:\/\/doi.org\/10.1634\/THEONCOLOGIST.2017-0628","journal-title":"Oncologist"},{"key":"10343_CR39","doi-asserted-by":"publisher","DOI":"10.1200\/OP.23.00811","author":"SM Durbin","year":"2024","unstructured":"Durbin SM, Lundquist DM, Pelletier A et al (2024) Time toxicity experienced by early-phase cancer clinical trial participants. JCO Oncol Pract. https:\/\/doi.org\/10.1200\/OP.23.00811","journal-title":"JCO Oncol Pract"},{"key":"10343_CR40","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_433648","author":"K Spencer","year":"2024","unstructured":"Spencer K, Butenschoen H, Alger E, Bachini M, Cook N (2024) Amplifying the patient\u2019s voice in oncology early-phase clinical trials: solutions to burdens and barriers. Am Soc Clin Oncol Educ Book. https:\/\/doi.org\/10.1200\/EDBK_433648","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"2","key":"10343_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1200\/JCO.2016.67.9902","volume":"35","author":"J Kimmelman","year":"2017","unstructured":"Kimmelman J (2017) Is Participation in Cancer Phase I Trials Really Therapeutic? J Clin Oncol 35(2):135\u2013138. https:\/\/doi.org\/10.1200\/JCO.2016.67.9902","journal-title":"J Clin Oncol"},{"issue":"23","key":"10343_CR42","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1200\/JCO.2011.38.0758","volume":"30","author":"S Fu","year":"2012","unstructured":"Fu S, Barber FD, Naing A et al (2012) Advance care planning in patients with cancer referred to a phase I clinical trials program: the MD Anderson Cancer Center experience. J Clin Oncol 30(23):2891\u20132896. https:\/\/doi.org\/10.1200\/JCO.2011.38.0758","journal-title":"J Clin Oncol"},{"issue":"10","key":"10343_CR43","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1089\/JPM.2014.0431","volume":"18","author":"SC Ahluwalia","year":"2015","unstructured":"Ahluwalia SC, Tisnado DM, Walling AM et al (2015) Association of early patient-physician care planning discussions and end-of-life care intensity in advanced cancer. J Palliat Med 18(10):834\u2013841. https:\/\/doi.org\/10.1089\/JPM.2014.0431","journal-title":"J Palliat Med"},{"issue":"6","key":"10343_CR44","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1188\/19.CJON.592-598","volume":"23","author":"AB Ferrell","year":"2019","unstructured":"Ferrell AB, William AC, Borneman T, Chung V, Smith TJ (2019) Clinical Trials: Understanding Patient Perspectives and Beliefs About Treatment. Clin J Oncol Nurs 23(6):592\u2013598. https:\/\/doi.org\/10.1188\/19.CJON.592-598","journal-title":"Clin J Oncol Nurs"},{"issue":"5","key":"10343_CR45","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1200\/JCO.1995.13.5.1062","volume":"13","author":"C Daugherty","year":"1995","unstructured":"Daugherty C, Ratain MJ, Grochowski E et al (1995) Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol 13(5):1062\u20131072. https:\/\/doi.org\/10.1200\/JCO.1995.13.5.1062","journal-title":"J Clin Oncol"},{"issue":"7","key":"10343_CR46","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1200\/JCO.1998.16.7.2305","volume":"16","author":"CK Daugherty","year":"1998","unstructured":"Daugherty CK, Ratain MJ, Minami H et al (1998) Study of cohort-specific consent and patient control in phase I cancer trials. J Clin Oncol 16(7):2305\u20132312. https:\/\/doi.org\/10.1200\/JCO.1998.16.7.2305","journal-title":"J Clin Oncol"},{"issue":"5","key":"10343_CR47","first-page":"891","volume":"24","author":"LH Yoder","year":"1997","unstructured":"Yoder LH, O\u2019Rourke TJ, Etnyre A, Spears DT, Brown TD (1997) Expectations and experiences of patients with cancer participating in phase i clinical trials. Oncol Nurs Forum 24(5):891\u2013896","journal-title":"Oncol Nurs Forum"},{"issue":"13","key":"10343_CR48","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1200\/JCO.2003.10.072","volume":"21","author":"NJ Meropol","year":"2003","unstructured":"Meropol NJ, Weinfurt KP, Burnett CB et al (2003) Perceptions of patients and physicians regarding phase I cancer clinical trials: Implications for physician-patient communication. J Clin Oncol 21(13):2589\u20132596. https:\/\/doi.org\/10.1200\/JCO.2003.10.072","journal-title":"J Clin Oncol"},{"issue":"2","key":"10343_CR49","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1200\/JCO.2000.18.2.421","volume":"18","author":"JD Cheng","year":"2000","unstructured":"Cheng JD, Hitt J, Koczwara B et al (2000) Impact of quality of life on patient expectations regarding phase I clinical trials. J Clin Oncol 18(2):421\u2013428. https:\/\/doi.org\/10.1200\/JCO.2000.18.2.421","journal-title":"J Clin Oncol"},{"issue":"10","key":"10343_CR50","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1002\/1097-0142(20010515)91:10<1949::aid-cncr1218>3.0.co;2-a","volume":"91","author":"L Cohen","year":"2001","unstructured":"Cohen L, de Moor C, Amato RJ (2001) The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a Phase I cancer clinical trial. Cancer 91(10):1949\u20131955. https:\/\/doi.org\/10.1002\/1097-0142(20010515)91:10%3c1949::aid-cncr1218%3e3.0.co;2-a","journal-title":"Cancer"},{"issue":"10","key":"10343_CR51","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/S00520-003-0496-Y","volume":"11","author":"PR Helft","year":"2003","unstructured":"Helft PR, Hlubocky F, Wen M, Daugherty CK (2003) Associations among awareness of prognosis, hopefulness, and coping in patients with advanced cancer participating in phase I clinical trials. Support Care Cancer 11(10):644\u2013651. https:\/\/doi.org\/10.1007\/S00520-003-0496-Y","journal-title":"Support Care Cancer"},{"issue":"5","key":"10343_CR52","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1200\/JCO.2005.03.9800","volume":"25","author":"FJ Hlubocky","year":"2007","unstructured":"Hlubocky FJ, Ratain MJ, Wen M, Daugherty CK (2007) Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making. J Clin Oncol 25(5):548\u2013554. https:\/\/doi.org\/10.1200\/JCO.2005.03.9800","journal-title":"J Clin Oncol"},{"key":"10343_CR53","unstructured":"Jansen LA, Appelbaum PS, Klein WMP et al (2011) Unrealistic Optimism in Early-Phase Oncology Trials. IRB 33(1):1. Accessed September 24, 2024. \/pmc\/articles\/PMC3095438\/"},{"issue":"18","key":"10343_CR54","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1002\/CNCR.27397","volume":"118","author":"RD Pentz","year":"2012","unstructured":"Pentz RD, White M, Harvey RD et al (2012) Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials. Cancer 118(18):4571\u20134578. https:\/\/doi.org\/10.1002\/CNCR.27397","journal-title":"Cancer"},{"issue":"22","key":"10343_CR55","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1002\/CNCR.30235","volume":"122","author":"SO Dolly","year":"2016","unstructured":"Dolly SO, Kalaitzaki E, Puglisi M et al (2016) A study of motivations and expectations of patients seen in phase 1 oncology clinics. Cancer 122(22):3501. https:\/\/doi.org\/10.1002\/CNCR.30235","journal-title":"Cancer"},{"issue":"2","key":"10343_CR56","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1200\/OP.20.00646","volume":"17","author":"FJ Hlubocky","year":"2021","unstructured":"Hlubocky FJ, Sher TG, Cella D, Wroblewski KE, Peppercorn J, Daugherty CK (2021) Anxiety Shapes Expectations of Therapeutic Benefit in Phase I Trials for Patients With Advanced Cancer and Spousal Caregivers. JCO Oncol Pract 17(2):e101. https:\/\/doi.org\/10.1200\/OP.20.00646","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"10343_CR57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1200\/JCO.2010.30.0814","volume":"29","author":"V Jenkins","year":"2011","unstructured":"Jenkins V, Solis-Trapala I, Langridge C, Catt S, Talbot DC, Fallowfield LJ (2011) What oncologists believe they said and what patients believe they heard: an analysis of phase I trial discussions. J Clin Oncol 29(1):61\u201368. https:\/\/doi.org\/10.1200\/JCO.2010.30.0814","journal-title":"J Clin Oncol"},{"key":"10343_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70215-7","author":"SY Zafar","year":"2012","unstructured":"Zafar SY, Currow DC, Cherny N, Strasser F, Fowler R, Abernethy AP (2012) Consensus-based standards for best supportive care in clinical trials in advanced cancer. Lancet Oncol. https:\/\/doi.org\/10.1016\/S1470-2045(11)70215-7","journal-title":"Lancet Oncol"},{"issue":"6","key":"10343_CR59","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/PON.5380","volume":"29","author":"B Ferrell","year":"2020","unstructured":"Ferrell B, Chung V, Koczywas M et al (2020) Spirituality in cancer patients on phase 1 clinical trials. Psychooncology 29(6):1077\u20131083. https:\/\/doi.org\/10.1002\/PON.5380","journal-title":"Psychooncology"},{"issue":"4","key":"10343_CR60","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3322\/CAAC.21187","volume":"63","author":"JR Peteet","year":"2013","unstructured":"Peteet JR, Balboni MJ (2013) Spirituality and religion in oncology. CA Cancer J Clin 63(4):280\u2013289. https:\/\/doi.org\/10.3322\/CAAC.21187","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10343_CR61","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/S13187-020-01941-9","volume":"36","author":"M Evans Webb","year":"2021","unstructured":"Evans Webb M, Murray E, Younger ZW, Goodfellow H, Ross J (2021) The supportive care needs of cancer patients: a systematic review. J Cancer Educ 36(5):899\u2013908. https:\/\/doi.org\/10.1007\/S13187-020-01941-9","journal-title":"J Cancer Educ"},{"issue":"2","key":"10343_CR62","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1634\/THEONCOLOGIST.2019-0289","volume":"25","author":"R Jain","year":"2020","unstructured":"Jain R, Handorf E, Khare V, Blau M, Chertock Y, Hall MJ (2020) Impact of baseline nutrition and exercise status on toxicity and outcomes in phase I and II oncology clinical trial participants. Oncologist 25(2):161\u2013169. https:\/\/doi.org\/10.1634\/THEONCOLOGIST.2019-0289","journal-title":"Oncologist"},{"issue":"1","key":"10343_CR63","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1040-8428(03)00095-7","volume":"49","author":"PK Rauch","year":"2004","unstructured":"Rauch PK, Muriel AC (2004) The importance of parenting concerns among patients with cancer. Crit Rev Oncol Hematol 49(1):37\u201342. https:\/\/doi.org\/10.1016\/S1040-8428(03)00095-7","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10343_CR64","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/PON.1620","volume":"19","author":"M Niemel\u00e4","year":"2010","unstructured":"Niemel\u00e4 M, Hakko H, R\u00e4s\u00e4nen S (2010) A systematic narrative review of the studies on structured child-centred interventions for families with a parent with cancer. Psychooncology 19(5):451\u2013461. https:\/\/doi.org\/10.1002\/PON.1620","journal-title":"Psychooncology"},{"issue":"3","key":"10343_CR65","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S1470-2045(18)30060-3","volume":"19","author":"G Vanbutsele","year":"2018","unstructured":"Vanbutsele G, Pardon K, Van Belle S et al (2018) Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial. Lancet Oncol 19(3):394\u2013404. https:\/\/doi.org\/10.1016\/S1470-2045(18)30060-3","journal-title":"Lancet Oncol"},{"key":"10343_CR66","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/J.EJCA.2019.11.009","volume":"124","author":"G Vanbutsele","year":"2020","unstructured":"Vanbutsele G, Van Belle S, Surmont V et al (2020) The effect of early and systematic integration of palliative care in oncology on quality of life and health care use near the end of life: a randomised controlled trial. Eur J Cancer 124:186\u2013193. https:\/\/doi.org\/10.1016\/J.EJCA.2019.11.009","journal-title":"Eur J Cancer"},{"key":"10343_CR67","doi-asserted-by":"publisher","unstructured":"Haun MW, Estel S, R\u00fccker G, et al. Early palliative care for adults with advanced cancer. Cochrane Database of Systematic Reviews. 2017;2017(6). https:\/\/doi.org\/10.1002\/14651858.CD011129.pub2","DOI":"10.1002\/14651858.CD011129.pub2"},{"key":"10343_CR68","doi-asserted-by":"publisher","unstructured":"Smith GL, Banegas MP, Chiara Acquati ;, et al. Navigating financial toxicity in patients with cancer: A multidisciplinary management approach. CA Cancer J Clin. 2022;72(5):437\u2013453. https:\/\/doi.org\/10.3322\/CAAC.21730","DOI":"10.3322\/CAAC.21730"},{"issue":"5","key":"10343_CR69","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3322\/CAAC.21672","volume":"71","author":"TL Deshields","year":"2021","unstructured":"Deshields TL, Gregorio SWD, Flowers SR et al (2021) Addressing distress management challenges: Recommendations from the consensus panel of the American Psychosocial Oncology Society and the Association of Oncology Social Work. CA Cancer J Clin 71(5):407\u2013436. https:\/\/doi.org\/10.3322\/CAAC.21672","journal-title":"CA Cancer J Clin"},{"key":"10343_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153860","author":"F Scott\u00e9","year":"2023","unstructured":"Scott\u00e9 F, Taylor A, Davies A (2023) Supportive Care: The \u201cKeystone\u201d of Modern Oncology Practice. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15153860","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10343_CR71","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.clon.2020.07.020","volume":"32","author":"R Berman","year":"2020","unstructured":"Berman R, Davies A, Cooksley T et al (2020) Supportive Care: An Indispensable Component of Modern Oncology. Clin Oncol (R Coll Radiol) 32(11):781\u2013788. https:\/\/doi.org\/10.1016\/j.clon.2020.07.020","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"9","key":"10343_CR72","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1200\/JCO.18.02123\/ASSET\/IMAGES\/LARGE\/JCO.18.02123T5.JPEG","volume":"38","author":"D Hui","year":"2020","unstructured":"Hui D, Bruera E (2020) Models of palliative care delivery for patients with cancer. J Clin Oncol 38(9):852\u2013865. https:\/\/doi.org\/10.1200\/JCO.18.02123\/ASSET\/IMAGES\/LARGE\/JCO.18.02123T5.JPEG","journal-title":"J Clin Oncol"},{"issue":"4","key":"10343_CR73","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/ONCO.13625","volume":"26","author":"D Hausner","year":"2021","unstructured":"Hausner D, Tricou C, Mathews J et al (2021) Timing of palliative care referral before and after evidence from trials supporting early palliative care. Oncologist 26(4):332. https:\/\/doi.org\/10.1002\/ONCO.13625","journal-title":"Oncologist"},{"issue":"29_suppl","key":"10343_CR74","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1200\/JCO.2020.38.29_SUPPL.28","volume":"38","author":"A Johnson","year":"2020","unstructured":"Johnson A, Nipp RD, Jimenez R et al (2020) Involvement of social work services in patients with advanced cancer in early-phase clinical trials (EP-CTs). J Clin Oncol 38(29_suppl):28\u201328. https:\/\/doi.org\/10.1200\/JCO.2020.38.29_SUPPL.28","journal-title":"J Clin Oncol"},{"issue":"10","key":"10343_CR75","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1089\/JPM.2011.9634","volume":"14","author":"RS Morrison","year":"2011","unstructured":"Morrison RS, Augustin R, Souvanna P, Meier DE (2011) America\u2019s care of serious illness: a state-by-state report card on access to palliative care in our nation\u2019s hospitals. J Palliat Med 14(10):1094. https:\/\/doi.org\/10.1089\/JPM.2011.9634","journal-title":"J Palliat Med"},{"key":"10343_CR76","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/ANNUREV-PUBLHEALTH-032013-182406","volume":"35","author":"MT Hughes","year":"2014","unstructured":"Hughes MT, Smith TJ (2014) The growth of palliative care in the United States. Annu Rev Public Health 35:459\u2013475. https:\/\/doi.org\/10.1146\/ANNUREV-PUBLHEALTH-032013-182406","journal-title":"Annu Rev Public Health"},{"issue":"11","key":"10343_CR77","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1001\/JAMA.2010.258","volume":"303","author":"D Hui","year":"2010","unstructured":"Hui D, Elsayem A, De La Cruz M et al (2010) Availability and integration of palliative care at US cancer centers. JAMA 303(11):1054\u20131061. https:\/\/doi.org\/10.1001\/JAMA.2010.258","journal-title":"JAMA"},{"issue":"8","key":"10343_CR78","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1177\/0269216314526272","volume":"28","author":"A Brinkman-Stoppelenburg","year":"2014","unstructured":"Brinkman-Stoppelenburg A, Rietjens JAC, Van Der Heide A (2014) The effects of advance care planning on end-of-life care: A systematic review. Palliat Med 28(8):1000\u20131025. https:\/\/doi.org\/10.1177\/0269216314526272","journal-title":"Palliat Med"},{"key":"10343_CR79","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.C1345","volume":"340","author":"KM Detering","year":"2010","unstructured":"Detering KM, Hancock AD, Reade MC, Silvester W (2010) The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ 340:c1345. https:\/\/doi.org\/10.1136\/BMJ.C1345","journal-title":"BMJ"},{"issue":"11","key":"10343_CR80","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1001\/JAMA.283.11.1437","volume":"283","author":"DW Molloy","year":"2000","unstructured":"Molloy DW, Guyatt GH, Russo R et al (2000) Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA 283(11):1437\u20131444. https:\/\/doi.org\/10.1001\/JAMA.283.11.1437","journal-title":"JAMA"},{"issue":"2","key":"10343_CR81","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1532-5415.2007.01045.x","volume":"55","author":"JM Teno","year":"2007","unstructured":"Teno JM, Gruneir A, Schwartz Z, Nanda A, Wetle T (2007) Association between advance directives and quality of end-of-life care: a national study. J Am Geriatr Soc 55(2):189\u2013194. https:\/\/doi.org\/10.1111\/j.1532-5415.2007.01045.x","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10343_CR82","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/JGS.16801","volume":"69","author":"RD McMahan","year":"2021","unstructured":"McMahan RD, Tellez I, Sudore RL (2021) Deconstructing the complexities of advance care planning outcomes: what do we know and where do we go? a scoping review. J Am Geriatr Soc 69(1):234\u2013244. https:\/\/doi.org\/10.1111\/JGS.16801","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"10343_CR83","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/J.JPAINSYMMAN.2016.12.331","volume":"53","author":"RL Sudore","year":"2017","unstructured":"Sudore RL, Lum HD, You JJ et al (2017) Defining advance care planning for adults: a consensus definition from a multidisciplinary Delphi panel. J Pain Symptom Manage 53(5):821-832.e1. https:\/\/doi.org\/10.1016\/J.JPAINSYMMAN.2016.12.331","journal-title":"J Pain Symptom Manage"},{"key":"10343_CR84","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.1744","author":"JM Peppercorn","year":"2011","unstructured":"Peppercorn JM, Smith TJ, Helft PR et al (2011) American Society of Clinical Oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2010.33.1744","journal-title":"J Clin Oncol"},{"key":"10343_CR85","doi-asserted-by":"publisher","unstructured":"Schrijvers D, Cherny NI (2014) ESMO Clinical Practice Guidelines on palliative care: advanced care planning. Ann Oncol 25 Suppl 3:iii138-iii142. https:\/\/doi.org\/10.1093\/ANNONC\/MDU241","DOI":"10.1093\/ANNONC\/MDU241"},{"key":"10343_CR86","unstructured":"Centers for Medicare and Medicaid Services (2024) Chapter 15 \u2013 Covered Medical and Other Health Services. In: Medicare Benefit Policy Manual. Accessed September 18, 2024. chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/www.cms.gov\/medicare\/prevention\/prevntiongeninfo\/downloads\/bp102c15.pdf"},{"key":"10343_CR87","doi-asserted-by":"publisher","unstructured":"Committee on Approaching Death (2015) Addressing Key End of Life Issues; Institute of Medicine. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. Published online April 19 1\u2013638. https:\/\/doi.org\/10.17226\/18748","DOI":"10.17226\/18748"},{"key":"10343_CR88","unstructured":"Centers for Medicare & Medicaid Services. Oncology Care Model. Accessed September 18, 2024. https:\/\/ innovation.cms.gov\/initiatives\/oncology-care\/"},{"issue":"4","key":"10343_CR89","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1377\/HLTHAFF.2020.01895\/ASSET\/IMAGES\/LARGE\/FIGUREEX3.JPEG","volume":"40","author":"MK Palmer","year":"2021","unstructured":"Palmer MK, Jacobson M, Enguidanos S (2021) Advance care planning for medicare beneficiaries increased substantially, but prevalence remained low. Health Aff 40(4):613\u2013621. https:\/\/doi.org\/10.1377\/HLTHAFF.2020.01895\/ASSET\/IMAGES\/LARGE\/FIGUREEX3.JPEG","journal-title":"Health Aff"},{"issue":"2","key":"10343_CR90","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1200\/JCO.2009.24.6397","volume":"28","author":"LA Dow","year":"2010","unstructured":"Dow LA, Matsuyama RK, Ramakrishnan V et al (2010) Paradoxes in advance care planning: the complex relationship of oncology patients, their physicians, and advance medical directives. J Clin Oncol 28(2):299\u2013304. https:\/\/doi.org\/10.1200\/JCO.2009.24.6397","journal-title":"J Clin Oncol"},{"issue":"10","key":"10343_CR91","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1200\/JOP2017021246","volume":"13","author":"CM Bestvina","year":"2017","unstructured":"Bestvina CM, Polite BN (2017) Implementation of advance care planning in oncology: a review of the literature. J Oncol Pract 13(10):657\u2013662. https:\/\/doi.org\/10.1200\/JOP2017021246","journal-title":"J Oncol Pract"},{"issue":"32","key":"10343_CR92","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1200\/JCO.2015.61.9239","volume":"33","author":"AC Enzinger","year":"2015","unstructured":"Enzinger AC, Zhang B, Schrag D, Prigerson HG (2015) Outcomes of prognostic disclosure: associations with prognostic understanding, distress, and relationship with physician among patients with advanced cancer. J Clin Oncol 33(32):3809\u20133816. https:\/\/doi.org\/10.1200\/JCO.2015.61.9239","journal-title":"J Clin Oncol"},{"issue":"12","key":"10343_CR93","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1001\/jamainternmed.2013.903","volume":"173","author":"TA Balboni","year":"2013","unstructured":"Balboni TA, Balboni M, Enzinger AC et al (2013) Provision of spiritual support to patients with advanced cancer by religious communities and associations with medical care at the end of life. JAMA Intern Med 173(12):1109. https:\/\/doi.org\/10.1001\/jamainternmed.2013.903","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10343_CR94","doi-asserted-by":"publisher","first-page":"396","DOI":"10.4037\/AJCC2012223","volume":"21","author":"DB White","year":"2012","unstructured":"White DB, Cua SM, Walk R et al (2012) Nurse-led intervention to improve surrogate decision making for patients with advanced critical illness. Am J Crit Care 21(6):396\u2013409. https:\/\/doi.org\/10.4037\/AJCC2012223","journal-title":"Am J Crit Care"},{"issue":"4","key":"10343_CR95","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/15524256.2021.1910107","volume":"17","author":"J Russell","year":"2021","unstructured":"Russell J, Quaack K (2021) A multiple goals approach to exploring social worker conversational plans for advance care treatment with terminally ill patients. J Soc Work End-Life Palliat Care 17(4):278\u2013295. https:\/\/doi.org\/10.1080\/15524256.2021.1910107","journal-title":"J Soc Work End-Life Palliat Care"},{"issue":"4","key":"10343_CR96","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1200\/JOP.2017.025221","volume":"14","author":"BS Gannavarapu","year":"2018","unstructured":"Gannavarapu BS, Lau SKM, Carter K et al (2018) Prevalence and survival impact of pretreatment cancer-associated weight loss: a tool for guiding early palliative care. J Oncol Pract 14(4):e238\u2013e250. https:\/\/doi.org\/10.1200\/JOP.2017.025221","journal-title":"J Oncol Pract"},{"issue":"11","key":"10343_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11912-017-0631-4\/METRICS","volume":"19","author":"A Baronner","year":"2017","unstructured":"Baronner A, MacKenzie A (2017) Using Geriatric Assessment Strategies to Lead End-of-Life Care Discussions. Curr Oncol Rep 19(11):1\u20136. https:\/\/doi.org\/10.1007\/S11912-017-0631-4\/METRICS","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"10343_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-07988-1","volume":"21","author":"N Takemura","year":"2021","unstructured":"Takemura N, Chan SL, Smith R, Cheung DST, Lin CC (2021) The effects of physical activity on overall survival among advanced cancer patients: a systematic review and meta-analysis. BMC Cancer 21(1):242. https:\/\/doi.org\/10.1186\/s12885-021-07988-1","journal-title":"BMC Cancer"},{"issue":"9","key":"10343_CR99","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.1016\/S1470-2045(17)30582-X","volume":"18","author":"JAC Rietjens","year":"2017","unstructured":"Rietjens JAC, Sudore RL, Connolly M et al (2017) Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care. Lancet Oncol 18(9):e543\u2013e551. https:\/\/doi.org\/10.1016\/S1470-2045(17)30582-X","journal-title":"Lancet Oncol"},{"issue":"2","key":"10343_CR100","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1378\/CHEST.06-2088","volume":"131","author":"T Lang","year":"2007","unstructured":"Lang T (2007) Documenting research in scientific articles: Guidelines for authors: 3 Reporting multivariate analyses. Chest 131(2):628\u2013632. https:\/\/doi.org\/10.1378\/CHEST.06-2088","journal-title":"Chest"},{"issue":"5","key":"10343_CR101","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1017\/S1478951519001068","volume":"18","author":"S Koffler","year":"2020","unstructured":"Koffler S, Mintzker Y, Shai A (2020) Association between palliative care and the rate of advanced care planning: a systematic review. Palliat Support Care 18(5):589\u2013601. https:\/\/doi.org\/10.1017\/S1478951519001068","journal-title":"Palliat Support Care"},{"issue":"8","key":"10343_CR102","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jclinepi.2014.03.012","volume":"67","author":"ME Glickman","year":"2014","unstructured":"Glickman ME, Rao SR, Schultz MR (2014) False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol 67(8):850\u2013857. https:\/\/doi.org\/10.1016\/j.jclinepi.2014.03.012","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10343_CR103","doi-asserted-by":"publisher","first-page":"439","DOI":"10.6004\/JNCCN.2016.0050","volume":"14","author":"EJ Roeland","year":"2016","unstructured":"Roeland EJ, Triplett DP, Matsuno RK et al (2016) Patterns of palliative care consultation among elderly patients with cancer. J Natl Compr Canc Netw 14(4):439\u2013445. https:\/\/doi.org\/10.6004\/JNCCN.2016.0050","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"10343_CR104","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/1049909118809975","volume":"36","author":"M Rubens","year":"2018","unstructured":"Rubens M, Ramamoorthy V, Saxena A et al (2018) Palliative care consultation trends among hospitalized patients with advanced cancer in the United States, 2005 to 2014. American J Hospice Palliative Med\u00ae 36(4):294\u2013301. https:\/\/doi.org\/10.1177\/1049909118809975","journal-title":"American J Hospice Palliative Med\u00ae"},{"issue":"1","key":"10343_CR105","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/PON.4910","volume":"28","author":"J Hamilton","year":"2019","unstructured":"Hamilton J, Kroska EB (2019) Distress predicts utilization of psychosocial health services in oncology patients. Psychooncology 28(1):61\u201367. https:\/\/doi.org\/10.1002\/PON.4910","journal-title":"Psychooncology"},{"issue":"10","key":"10343_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS14102567","volume":"14","author":"MC Jin","year":"2022","unstructured":"Jin MC, Hsin G, Ratliff J et al (2022) Modifiers of and disparities in palliative and supportive care timing and utilization among neurosurgical patients with malignant central nervous system tumors. Cancers 14(10):2567. https:\/\/doi.org\/10.3390\/CANCERS14102567","journal-title":"Cancers"},{"issue":"3","key":"10343_CR107","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1200\/JOP.2015.003954","volume":"11","author":"AC Chiang","year":"2015","unstructured":"Chiang AC, Amport SB, Corjulo D, Harvey KL, McCorkle R (2015) Incorporating patient-reported outcomes to improve emotional distress screening and assessment in an ambulatory oncology clinic. J Oncol Pract 11(3):219\u2013222. https:\/\/doi.org\/10.1200\/JOP.2015.003954","journal-title":"J Oncol Pract"},{"issue":"5","key":"10343_CR108","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1200\/JCO.2007.15.4864","volume":"27","author":"J Ellis","year":"2009","unstructured":"Ellis J, Lin J, Walsh A et al (2009) Predictors of referral for specialized psychosocial oncology care in patients with metastatic cancer: the contributions of age, distress, and marital status. J Clin Oncol 27(5):699\u2013705. https:\/\/doi.org\/10.1200\/JCO.2007.15.4864","journal-title":"J Clin Oncol"},{"issue":"2","key":"10343_CR109","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/J.JPAINSYMMAN.2017.08.025","volume":"55","author":"RL Sudore","year":"2018","unstructured":"Sudore RL, Heyland DK, Lum HD et al (2018) Outcomes that define successful advance care planning: a delphi panel consensus. J Pain Symptom Manage 55(2):245-255.e8. https:\/\/doi.org\/10.1016\/J.JPAINSYMMAN.2017.08.025","journal-title":"J Pain Symptom Manage"},{"issue":"10","key":"10343_CR110","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.3390\/cancers13102304","volume":"13","author":"JAJ Douma","year":"2021","unstructured":"Douma JAJ, Buffart LM, Sedhom R et al (2021) Clinical predictors of early trial discontinuation for patients participating in phase I clinical trials in oncology. Cancers (Basel) 13(10):2304","journal-title":"Cancers (Basel)"},{"issue":"16_suppl","key":"10343_CR111","doi-asserted-by":"publisher","first-page":"11101","DOI":"10.1200\/JCO.2024.42.16_suppl.11101","volume":"42","author":"AB Lam","year":"2024","unstructured":"Lam AB, Lundquist D, Pelletier A et al (2024) Associations of symptom burden with patient-reported outcomes (PROs) and clinical outcomes among early-phase cancer clinical trial (EP-CT) participants. J Clin Oncol 42(16_suppl):11101\u201311101","journal-title":"J Clin Oncol"},{"issue":"16_suppl","key":"10343_CR112","doi-asserted-by":"publisher","first-page":"12084","DOI":"10.1200\/JCO.2024.42.16_suppl.12084","volume":"42","author":"GC George","year":"2024","unstructured":"George GC, Piha-Paul SA, Dumbrava EE et al (2024) Patient-reported symptom interference with activity- and mood-related functioning prior to start of an early-phase oncology combination trial including immune checkpoint blockade. J Clin Oncol 42(16_suppl):12084\u201312084","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10343-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10343-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10343-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:20:47Z","timestamp":1791271247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10343-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10343"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10343-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All provided final approval of the manuscript and agree to be accountable for all aspects of the work.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"112"}}